We report a comprehensive assessment and validation of a new intraoperative angiography technique. BACKGROUND Technical problems at the site of the distal anastomosis compromise an underappreciated proportion of coronary bypass grafts. The absence of a systematic, validated technique to verify graft patency in the operating room represents a significant breach in quality assurance.
Graft patency is the major determinant of survival and freedom from repeat intervention after coronary bypass surgery. The construction of a technically perfect anastomosis at the time of surgery is an important determinant of graft patency. Modern coronary bypass series report perioperative graft occlusion rates as high as 11% (1, 2) . Technical errors in bypass graft construction by the operating surgeon are primarily responsible for these early failures. There is currently no standardized approach for identifying these errors using any form of intraoperative graft assessment, and it is not routine clinical practice in most centers. We present reliability studies and validation of a simple technique of intraoperative fluorescent dye angiography that provides highfidelity angiographic images similar to those of catheterbased X-ray angiography.
MATERIALS AND METHODS
This study was a prospective evaluation of the reliability and validity of a new diagnostic imaging modality: indocyanine green (ICG) dye fluorescence angiography. Contrast agent. Indocyanine green is a negatively charged, polymethine tricarbocyanine dye (chemical formula C 43 H 47 N 2 NaO 6 S 2 ) with absorbance and fluorescence maxima in the near infrared (750 to 1,000 nanometer ϭ 1 billionth of a meter) region, where very few molecules show intrinsic fluorescence and there is little background fluorescence. When illuminated at 806 nm, ICG fluoresces to emit light centered at 830 nm. Indocyanine green is noncovalently (95%) bound to albumin and is not nephrotoxic. It is taken up from the plasma by hepatic parenchymal cells and secreted into the bile. Imaging device. The imaging device (Novadaq Technologies Inc., Concord, Ontario, Canada) is composed of an imaging head containing an 806-nm laser light source and a charge-coupled device video camera equipped with an optical filter to block transmission of visible and 806-nm light while optimizing transmission of ICG-fluoresced light at 830 nm. Eye protection is not required in the operating room because the laser light energy (2.0 W) is dispersed. The imaging head is positioned over the exposed heart, and the laser is activated before the first pass of a bolus of ICG through the field of view. Images of the coronary arteries and bypass grafts are acquired at a rate of 30 frames/s and may be viewed in real time. The near-infrared light can maximally penetrate 1 to 2 mm of soft tissue. The fluorescence sequentially shows illumination of the graft or coronary artery lumen, a blush of the epicardium as dye passes through the microcirculation, and finally, washout through the coronary veins. Optimal methods of dye injection for each type of graft in on-pump and off-pump coronary surgery were developed and are presented in Table 1 . Patients. All patients signed a consent form approved by the local institutional review ethics board after being approached by a study coordinator who was not affiliated with their clinical care. Operations were performed by six experienced surgeons who each perform at least 200 cardiac operations per year. Exclusion criteria included allergy to ICG dye and cardiogenic shock.
Patients underwent coronary bypass surgery according to the standard technique, and ICG angiography was performed on all bypass grafts. Grafts deemed to be occluded by ICG angiography in the operating room underwent revision, and operative findings were noted. Images were assessed off-line for determination of surgeon-specified image quality and inter-rater agreement. A small subgroup of six patients with 22 grafts underwent subsequent catheter-based X-ray angiography a pilot study for a randomized clinical trial. The X-ray angiograms were read by a cardiologist blinded to the results of the intraoperative studies. Statistical methods. Categorical variables are presented as proportions and percentages, and continuous variables are presented as mean values with standard deviations. Comparison of means for surgeon assessment of quality of visualization were performed using one-way analysis of variance. Inter-rater agreement for graft revision, patency, and Thrombolysis In Myocardial Infarction (TIMI) flow grade (3) was determined using the Cohen kappa statistic. Sensitivity and specificity were calculated according to standard methods. Table 2 . Patients were generally representative of the overall coronary bypass population at our institution. Operative characteristics are presented in Table 3 . In total, 348 grafts were performed, with a mean of 2.9 grafts per patient. The vast majority of bypasses were performed on-pump, as is our routine clinical practice. A total of 432 ICG angiograms were performed, with a mean of 3.6 Ϯ 0.9 ICG angiograms performed per patient. Typically, we performed one angiogram for each distal anastomosis and one angiogram for all proximal anastomoses. Average time to perform one ICG angiogram was 2.2 Ϯ 1.1 min/patient. A representative angiogram of left internal mammary artery bypass graft is presented in Figure 1 .
RESULTS

Between
Using ICG angiography, we found that 4.2% (5 of 120) of patients had significant graft problems requiring major anastomotic revision or new graft construction. These graft GEA ϭ gastroepiploic artery; ICG ϭ indocyanine green; IMA ϭ internal mammary artery; LIMA ϭ left internal mammary artery; Off-pump ϭ performed without cardiopulmonary bypass on a beating heart; On-pump ϭ performed with cardiopulmonary bypass on an arrested heart; RIMA ϭ right internal mammary artery; SVG ϭ saphenous vein graft. 
problems included twisted vein graft (1), significant lesion in native vessel distal to the graft-coronary artery anastomosis (2), and technical problems at the anastomosis (2). A representative angiogram is shown in Figure 2 . A further four grafts (3.3%) required minor revision based on intraoperative findings. These included graft repositioning (1) and extra sutures to improve hemostasis (2).
Angiographic results are summarized in Table 4 . Quality of visualization was rated according to a seven-point Likert scale (1 ϭ worst, 7 ϭ best). Among conduits, saphenous veins were best visualized (mean score Ϯ standard deviation) 6.4 Ϯ 1.5 versus 5.5 Ϯ 1.9 for internal mammary arteries and 4.4 Ϯ 2.3 for radial arteries, analysis of variance overall p ϭ 0.02. Location of distal anastomosis did not influence quality of visualization.
Inter-rater agreement among two surgeons, one experienced and one inexperienced with the technique, was 100% (Cohen kappa ϭ 1.0) for assessing total graft occlusion and 97% (Cohen kappa ϭ 0.9) for assessing graft revision when 35 ICG angiograms were reviewed off-line. Inter-rater agreement for assessing TIMI flow grade was only 60% (Cohen kappa ϭ 0.4).
As part of a pilot investigation for a randomized clinical trial, six patients, with a total of 22 bypass grafts, underwent gold-standard post-operative X-ray angiography for comparison with ICG angiogram images. Perianastomotic lesions with Ͼ50% stenosis or graft occlusion were observed in three grafts (i.e., there were three true positives). The 
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Intraoperative Angiography in CABG sensitivity of ICG angiography to detect occlusion or Ͼ50% stenosis was 100% (3 positive ICG studies/3 true positives). There were no false positives, and specificity for ICG angiography for occlusion or Ͼ50% stenosis was also 100% (19 negative ICG studies/19 true negatives). Representative angiograms are shown in Figure 3 .
DISCUSSION
With the exception of coronary artery bypass surgery, virtually all other interventions on the heart, including cardiac valve repair and coronary stenting, are accompanied by completion diagnostic imaging to ensure an adequate technical result. Despite tremendous improvements in the quality of processes of care in cardiac surgery over the past decade, there is still no well-accepted or broadly used technique to assess the quality of the bypass graft itself. Recent angiographic trials by Puskas et al. (4) and Khan et al. (5) have shown significant clustering of the technical results of off-pump surgery at the level of the individual surgeon, highlighting the need for intraoperative quality assurance.
In this study, we determined that in a high-volume academic practice, nearly 1% of internal mammary artery grafts and 3% of saphenous vein grafts required graft revision when completion ICG angiography was performed for intraoperative quality assessment. When analyzed by patient, 4.2% of patients required graft revision. These results are similar to those of other groups who have used this technology (6, 7) . In all cases, the lesions would have otherwise been missed by the operating room team. The clinical consequences of early graft failure are not benign. A recent report suggests that the perioperative mortality in patients with unrecognized graft problems is over 9% (8) .
Among graft assessment techniques currently available, contrast dye X-ray coronary angiography is the gold standard. Difficulties incorporating bulky equipment into the cardiac operating room and safety concerns regarding nephrotoxicity and embolic/bleeding complications have limited implementation of intraoperative X-ray angiography. Graft assessment techniques such as thermal angiography, Doppler flow measurement, and electromagnetic flow measurement have also been attempted in the operating room with limited success (9 -12) . More recently, transit-time ultrasound flow measurement has gained significant implementation, particularly in off-pump coronary surgery. Despite the ease of use of this technique, several investigators have raised concerns regarding the diagnostic accuracy of transit-time flow measurements, particularly in non-occlusive stenoses (13) .
After promising pre-clinical investigations with this technique, we performed the first human studies in 2002 (14) . Subsequently, we have embarked on a rigorous systematic approach to intraoperative graft patency assessment using ICG angiography. The technique showed perfect inter-rater reliability for graft patency among two surgeons, one with significant experience in the technique and one with no previous experience with the technique, suggesting that interpretation of images does not require significant training or a learning curve. There was poor inter-rater reliability for graft TIMI flow grade. Because most free grafts in the series were hand injected, the subjective interpretation of TIMI flow grade was dependent on the rate of injection by the surgeon or assistant, which were not standardized. Pedicled grafts were less well seen with ICG angiography, likely because of fat and muscular tissue overlying the artery, which scatters the fluorescence signal. To improve pedicled graft visualization, our current practice is to partially skeletonize the distal portion of the graft from its overlying muscle and fat. For an average coronary bypass case, the total extra time needed to perform intraoperative patency assessment will be 8 to 10 min, including 6 or more minutes while the aortic cross-clamp is applied.
As part of a pilot study for a clinical trial, 22 grafts were also imaged with X-ray angiography. Included in his cohort were three grafts that intraoperatively were believed to have nonocclusive but Ͼ50% stenoses that were not corrected because of concerns regarding prolonging operative time. In these three grafts, gold-standard X-ray angiography confirmed that there was a true hemodynamically significant lesion. Because ICG angiography may be able to identify most graft lesions before chest closure, its potential effect on early graft patency may be greater than perioperative aspirin use, anti-lipid medications, and arterial grafting. Currently, drug-eluting stent therapies for coronary disease provide low single-digit early failure rates, and without high quality intraoperative patency assessment, it is unlikely that the periprocedural failure rates of coronary bypass grafts can remain competitive.
